108 related articles for article (PubMed ID: 7654355)
1. New approaches to hepatitis A and B vaccines.
Iwarson S
APMIS; 1995 May; 103(5):321-6. PubMed ID: 7654355
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
3. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
Chuai X; Xie B; Chen H; Tan X; Wang W; Huang B; Deng Y; Li W; Tan W
Vaccine; 2018 Jun; 36(26):3740-3746. PubMed ID: 29778513
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
Shouval D; Roggendorf H; Roggendorf M
Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
[TBL] [Abstract][Full Text] [Related]
6. [Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines].
Gerken G; Manns M; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):374-9. PubMed ID: 2851893
[TBL] [Abstract][Full Text] [Related]
7. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.
Shouval D; Ilan Y; Adler R; Deepen R; Panet A; Even-Chen Z; Gorecki M; Gerlich WH
Vaccine; 1994 Nov; 12(15):1453-9. PubMed ID: 7533967
[TBL] [Abstract][Full Text] [Related]
8. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
Krairittichai U; Sethakarun S
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
[TBL] [Abstract][Full Text] [Related]
11. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
[TBL] [Abstract][Full Text] [Related]
12. Immune response to hepatitis B virus proteins: relevance of the murine model.
Milich DR
Semin Liver Dis; 1991 May; 11(2):93-112. PubMed ID: 1832237
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccines.
Neurath AR; Strick N; Kent SB; Offensperger W; Wahl S; Christman JK; Acs G
J Virol Methods; 1985 Dec; 12(3-4):185-92. PubMed ID: 2422192
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
15. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
16. Nasal route favors the induction of CD4
Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
[TBL] [Abstract][Full Text] [Related]
18. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
[TBL] [Abstract][Full Text] [Related]
19. Properties of recombinant hepatitis B vaccine.
Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
[TBL] [Abstract][Full Text] [Related]
20. Prevention of perinatal transmission of hepatitis B virus (HBV) to children of e antigen-positive HBV carrier mothers by hepatitis B immune globulin and HBV vaccine.
Kanai K; Takehiro A; Noto H; Nishida M; Takahashi K; Kawashima Y; Igarashi Y; Matsushita K; Shimizu M
J Infect Dis; 1985 Feb; 151(2):287-90. PubMed ID: 3155779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
